Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders.
Showing 10 out of 26 products:
Human Polyclonal ACMSD Primary Antibody für ELISA, WB - ABIN566800
Guillemin, Cullen, Lim, Smythe, Garner, Kapoor, Takikawa, Brew: Characterization of the kynurenine pathway in human neurons. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
Acmsd gene expression was found to be under the control of both hepatocyte nuclear factor 4alpha (HNF4alpha (zeige HNF4A Antikörper)) and peroxisome proliferator-activated receptor alpha (PPARalpha (zeige PPARA Antikörper)).
The minor C allele of the ACMSD SNP rs2121337 was more prevalent in suicide attempters.
ACMSD is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism. ACMSD mutation contributes to the development of Familial cortical myoclonic tremor and epilepsy.
Data report a crystal structure of human ACMSD in complex with the glycolytic intermediate 1,3-dihydroxyacetonephosphate (DHAP (zeige ALDH3A2 Antikörper)),suggesting a regulatory link between NAD synthesis and glycolysis.
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase\; EC 220.127.116.11) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.
aminocarboxymuconate semialdehyde decarboxylase
, 2-amino-3-carboxylmuconate-6-semialdehyde decarboxylase
, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase-like
, picolinate carboxylase